Endo’s Par Sterile Products business has begun shipping bivalirudin injection in a ready-to-use 250 mg/50 ml single-use vial. It is the only ready-to-use liquid format of bivalirudin on the market in ...

Lugano, Switzerland – June 24, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive ...

Mumbai: Global tenders floated by Maharashtra government seeking liquid oxygen, oxygen concentrators and anti-viral remdesivir injections have received responses and it is likely work orders will be ...

Innovations in drug delivery such as needle-free transfer devices and vial adapters can provide consistency when transferring liquid for reconstitution of lyophilized drug products. Concerns for ...

Hospitals are experiencing a national shortage of sterile water for injection vials, according to the American Society of Health-System Pharmacists. Here are five things to know about the shortage. 1.

Only ready-to-use liquid format of bivalirudin on the market Does not require reconstitution, dilution or mixing, which helps increase efficiency for hospitals and healthcare providers DUBLIN, July 18 ...

Endo’s subsidiary Endo Ventures has reached an agreement with Maia Pharmaceuticals to distribute bivalirudin injection in a ready-to-use 250 mg/50 ml single-use vial in the United States. Endo will ...